Ultragenyx Pharmaceutical (RARE) Earnings Date & Reports

Industry: @Biotechnology

A.I. Advisor

published Earnings

RARE is expected to report earnings to fall 5.26% to -144 cents per share on October 29

Ultragenyx Pharmaceutical RARE Stock Earnings Reports

Q3'24

Est.

$-1.44

Q2'24

Beat

by $0.14

Q1'24

Missed

by $0.28

Q4'23

Beat

by $0.18

Q3'23

Missed

by $0.16

The last earnings report on August 01 showed earnings per share of -151 cents, beating the estimate of -165 cents. With 584.18K shares outstanding, the current market capitalization sits at 5.02B.

View a ticker or compare two or three

Compare

RARE

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if shorted

View Trends For RARE
(Try 14 days for $1 only)

Ad is loading...

A.I.Advisor

published price charts

View to see Real Time Patterns for RARE (Try 14 days for $1 only)

A.I. Advisor

published General Information

General Information

a developer of therapeutics for rare diseases

Industry Biotechnology

Profile

Fundamentals

Details

Industry

Biotechnology

Address

60 Leveroni Court

Phone

+1 415 483-8800

Employees

1276

Web

https://www.ultragenyx.com